Last $2.95 USD
Change Today +0.19 / 6.88%
Volume 151.7K
BTX On Other Exchanges
Symbol
Exchange
BTX is not on other exchanges.
As of 8:04 PM 04/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas B. Okarma M.D., Ph.D.

Chief Executive Officer of Biotime Acquisition Corp. and Director of Biotime Acquisition Corp., BioTime, Inc.
AgeTotal Calculated CompensationThis person is connected to 113 board members in 2 different organizations across 3 different industries.

See Board Relationships
67--

Background*

Dr. Thomas B. Okarma, M.D., Ph.D. served as the Chief Executive Officer of Asterias Biotherapeutics, Inc. from September 2012 to April 10, 2014 and also served as its President until April 10, 2014. Dr. Okarma served as the Chief Executive Officer of BioTime Acquisition Corp. since October 2012. He served as the Chief Executive Officer and President of Geron Corporation from July 1999 to February 9, 2011 and also served as its President of Oncology from January 2008 ...

Read Full Background

Corporate Headquarters*

1301 Harbor Bay Parkway
Alameda, California 94502

United States

Phone: 510-521-3390
Fax: 510-521-3389

Board Members Memberships*

Director
1999-2011
Former Chief Executive Officer, President, Director, Member of Stock Option Committee and Director of Geron Bio-Med Limited
2012-2014
Former Chief Executive Officer, President and Director

Education*

PhD
The Board of Trustees of The Leland Stanford Junior University
MD
The Board of Trustees of The Leland Stanford Junior University
BA
Dartmouth College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BTX:US $2.95 USD +0.19

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$568.8K
John A. Scarlett M.D.Chief Executive Officer, President and Director
Geron Corporation
$569.3K
Marc H. Hedrick M.D.Chief Executive Officer, President and Director
Cytori Therapeutics, Inc.
$406.6K
Robin L. Smith M.D., MBA,RoExecutive Chairman and Chief Executive Officer
Neostem, Inc.
$945.0K
Edward H. Myles MBAPrincipal Executive Officer, Interim President, Chief Financial Officer, Principal Accounting Officer and Executive Vice President of Corporate Development
Advanced Cell Technology Inc.
--
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTIME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.